Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Revenue $ 14,880 $ 23,488 $ 15,093
Operating expenses:      
Research and development 111,944 99,872 76,065
General and administrative 29,299 23,036 21,325
Transaction related expenses 9,510    
Total operating expenses 150,753 122,908 97,390
Loss from operations (135,873) (99,420) (82,297)
Interest income 2,132 87 426
Interest expense (4,134) (3,907) (1,792)
Change in fair value of warrant liabilities 43,221 16,682 (375)
Net loss applicable to common stockholders $ (94,654) $ (86,558) $ (84,038)
Net loss per share applicable to common stockholders - basic $ (7.49) $ (13.84) $ (18.20)
Net loss per share applicable to common stockholders - diluted $ (7.49) $ (13.84) $ (18.20)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic 12,631,968 6,253,498 4,605,162
Weighted-average number of common shares used in net loss per share applicable to common stockholders - diluted 12,631,968 6,253,498 4,605,162